Gaurav A Upadhyay to Middle Aged
This is a "connection" page, showing publications Gaurav A Upadhyay has written about Middle Aged.
Connection Strength
0.823
-
A Revised Definition of Left Bundle Branch Block Using Time to Notch in Lead I. JAMA Cardiol. 2024 May 01; 9(5):449-456.
Score: 0.060
-
Predicting Malignant Ventricular Arrhythmias Using Real-Time Remote Monitoring. J Am Coll Cardiol. 2023 03 14; 81(10):949-961.
Score: 0.055
-
Population-Level Impact of the Guidelines Update on Patient Selection and Outcomes After Cardiac Resynchronization Therapy. JACC Clin Electrophysiol. 2022 05; 8(5):651-661.
Score: 0.052
-
On-treatment comparison between corrective His bundle pacing and biventricular pacing for cardiac resynchronization: A secondary analysis of the His-SYNC Pilot Trial. Heart Rhythm. 2019 12; 16(12):1797-1807.
Score: 0.042
-
His Corrective Pacing or Biventricular Pacing for Cardiac Resynchronization in Heart Failure. J Am Coll Cardiol. 2019 07 09; 74(1):157-159.
Score: 0.042
-
Intracardiac Delineation of Septal Conduction in Left Bundle-Branch Block Patterns. Circulation. 2019 04 16; 139(16):1876-1888.
Score: 0.042
-
Intermittent left bundle branch block: What is the mechanism? J Cardiovasc Electrophysiol. 2019 08; 30(8):1380-1383.
Score: 0.042
-
Impact of Atrial Fibrillation Ablation on Recurrent Hospitalization: A Nationwide Cohort Study. JACC Clin Electrophysiol. 2019 03; 5(3):330-339.
Score: 0.041
-
Assessing mitral regurgitation in the prediction of clinical outcome after cardiac resynchronization therapy. Heart Rhythm. 2015 Jun; 12(6):1201-8.
Score: 0.032
-
The burden of inappropriate shocks in young people and how to avoid them. Heart. 2012 Oct; 98(19):1457-66.
Score: 0.027
-
Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN Trial. Circ Arrhythm Electrophysiol. 2024 Dec; 17(12):e012836.
Score: 0.016
-
Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN Trial. Circ Cardiovasc Qual Outcomes. 2024 11; 17(11):e010822.
Score: 0.015
-
Multicenter Hemodynamic Assessment of the LOT-CRT Strategy: When Does Combining Left Bundle Branch Pacing and Coronary Venous Pacing Enhance Resynchronization?: Primary Results of the CSPOT Study. Circ Arrhythm Electrophysiol. 2024 Nov; 17(11):e013059.
Score: 0.015
-
Rate-Dependent Pacemap Matching in Scar-Related Ventricular Tachycardia: Impact of "TR Fusion" Phenomenon. JACC Clin Electrophysiol. 2024 Oct; 10(10):2132-2144.
Score: 0.015
-
Procedural and Intermediate-term Results of the Electroanatomical-guided Cardioneuroablation for the Treatment of Supra-Hisian Second- or Advanced-degree Atrioventricular Block: the PIRECNA multicentre registry. Europace. 2024 Jul 02; 26(7).
Score: 0.015
-
Septal venous channel perforation during left bundle branch area pacing: a prospective study. Europace. 2024 Jun 03; 26(6).
Score: 0.015
-
Machine learning for prediction of ventricular arrhythmia episodes from intracardiac electrograms of automatic implantable cardioverter-defibrillators. Heart Rhythm. 2024 Nov; 21(11):2295-2302.
Score: 0.015
-
Side-to-side isoperistaltic strictureplasty in the treatment of extensive Crohn's disease. J Surg Res. 2004 Mar; 117(1):71-8.
Score: 0.015
-
Rescue left bundle branch area pacing in coronary venous lead failure or nonresponse to biventricular pacing: Results from International LBBAP Collaborative Study Group. Heart Rhythm. 2022 08; 19(8):1272-1280.
Score: 0.013
-
Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial. Circulation. 2022 02; 145(5):321-329.
Score: 0.013
-
Implantation of cardiac electronic devices in active COVID-19 patients: Results from an international survey. Heart Rhythm. 2022 02; 19(2):206-216.
Score: 0.013
-
Atypical pathogens associated with cardiac implantable electronic device infections. Pacing Clin Electrophysiol. 2021 Sep; 44(9):1549-1561.
Score: 0.012
-
Double loop ventricular tachycardia activation patterns with single loop mechanisms: Asymmetric entrainment responses during "pseudo-figure-of-eight" reentry. Heart Rhythm. 2021 09; 18(9):1548-1556.
Score: 0.012
-
Spatial and transmural properties of the reentrant ventricular tachycardia circuit in arrhythmogenic right ventricular cardiomyopathy: Simultaneous epicardial and endocardial recordings. Heart Rhythm. 2021 06; 18(6):916-925.
Score: 0.012
-
Prognostic value of cardiac magnetic resonance septal late gadolinium enhancement patterns for periaortic ventricular tachycardia ablation: Heterogeneity of the anteroseptal substrate in nonischemic cardiomyopathy. Heart Rhythm. 2021 04; 18(4):579-588.
Score: 0.012
-
Circuit Determinants of Ventricular Tachycardia Cycle Length: Characterization of Fast and Unstable Human Ventricular Tachycardia. Circulation. 2021 01 19; 143(3):212-226.
Score: 0.012
-
Left ventricular summit arrhythmias with an abrupt V3 transition: Anatomy of the aortic interleaflet triangle vantage point. Heart Rhythm. 2021 01; 18(1):10-19.
Score: 0.011
-
Characterization of Lead Adherence Using Intravascular Ultrasound to Assess Difficulty of Transvenous Lead Extraction. Circ Arrhythm Electrophysiol. 2020 08; 13(8):e007726.
Score: 0.011
-
Periaortic ventricular tachycardia in structural heart disease: Evidence of localized reentrant mechanisms. Heart Rhythm. 2020 08; 17(8):1271-1279.
Score: 0.011
-
Simultaneous Endocardial and Epicardial Delineation of 3D Reentrant Ventricular Tachycardia. J Am Coll Cardiol. 2020 03 03; 75(8):884-897.
Score: 0.011
-
High-Density Grid Catheter for Detailed Mapping of Sinus Rhythm and Scar-Related Ventricular Tachycardia: Comparison With a Linear Duodecapolar Catheter. JACC Clin Electrophysiol. 2020 03; 6(3):311-323.
Score: 0.011
-
Targeted Ablation of Ventricular Tachycardia Guided by Wavefront Discontinuities During Sinus Rhythm: A New Functional Substrate Mapping Strategy. Circulation. 2019 10 22; 140(17):1383-1397.
Score: 0.011
-
Feasibility of percutaneous epicardial mapping and ablation for refractory atrial fibrillation: Insights into substrate and lesion transmurality. Heart Rhythm. 2019 08; 16(8):1151-1159.
Score: 0.010
-
Prevalence and predictors of atrial arrhythmias in patients with sinus node dysfunction and atrial pacing. J Interv Card Electrophysiol. 2018 Dec; 53(3):365-371.
Score: 0.010
-
Impact of high-grade atrioventricular block and cumulative frequent pacing on atrial arrhythmias. Pacing Clin Electrophysiol. 2018 09; 41(9):1158-1164.
Score: 0.010
-
High-resolution mapping of the triangle of Koch: Spatial heterogeneity of fast pathway atrionodal connections. Heart Rhythm. 2018 03; 15(3):421-429.
Score: 0.010
-
Characterization of Ventricular Tachycardia After Left Ventricular Assist Device Implantation as Destination Therapy: A Single-Center Ablation Experience. JACC Clin Electrophysiol. 2017 12 11; 3(12):1412-1424.
Score: 0.009
-
Permanent His-bundle pacing for cardiac resynchronization therapy: Initial feasibility study in lieu of left ventricular lead. Heart Rhythm. 2017 09; 14(9):1353-1361.
Score: 0.009
-
Renal Response in Patients with Chronic Kidney Disease Predicts Outcome Following Cardiac Resynchronization Therapy. Pacing Clin Electrophysiol. 2015 Oct; 38(10):1192-200.
Score: 0.008
-
Does prior valve surgery change outcome in patients treated with cardiac resynchronization therapy? J Cardiovasc Electrophysiol. 2014 Nov; 25(11):1206-13.
Score: 0.008
-
Impact of myocardial viability and left ventricular lead location on clinical outcome in cardiac resynchronization therapy recipients with ischemic cardiomyopathy. J Cardiovasc Electrophysiol. 2014 May; 25(5):507-513.
Score: 0.007
-
Usefulness and consequences of cardiac resynchronization therapy in dialysis-dependent patients with heart failure. Am J Cardiol. 2013 Nov 15; 112(10):1625-31.
Score: 0.007
-
The anatomic and electrical location of the left ventricular lead predicts ventricular arrhythmia in cardiac resynchronization therapy. Heart Rhythm. 2013 May; 10(5):668-75.
Score: 0.007
-
Usefulness of hemoglobin A(1c) to predict outcome after cardiac resynchronization therapy in patients with diabetes mellitus and heart failure. Am J Cardiol. 2012 Sep 01; 110(5):683-8.
Score: 0.007